Претрага
Резултати
Preliminary analysis of a phase II, multicenter, randomized, active-control study to evaluate the efficacy and safety of eganelisib (IPI 549) in combination with nivolumab compared to nivolumab monotherapy in patients with advanced urothelial carcinoma.
[2021]
Tomczak, Piotr; Popovic, Lazar S
Zizlsperger, Nora; Zhang, Halle Huihong; Valderrama, Begona P;
2116 Antitumor activity of two ruthenium (Ru) compounds
[2005]
Radulović, Siniša Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
[2011]
Radosavljević, Davorin Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human Cancer [2008]
Kumar Amit; Petri EdwardMultiregion sequencing of penile cancer to reveal distinct patterns of heterogeneous actionable mutations
[2017]
Rodney Simon; Tanić, Miljana G.
Nigam R; Malone P; Muneer A; Beck S; Feber A; Kelly JD;
Cerebellar metastases as the only brain metastatic site and correlation with molecular characteristics of primary breast cancer.
[2017]
Tomašević, Zorica I. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer. [2015]
Nikolic, Srdjan S; Zegarac, Milan; Djurisic, Igor; Kocic, Milan; Markovic, Ivan Z; Dzodic, Radan RComparison of hormone receptor and HER2 status in resected brain metastases and primary breast cancer. [2010]
Tomasevic, Zoran M; Milovanovic, Zorka M; Tomasevic, Zoran M; Skender, Milica KEffect of PARP inhibitors on sensitivity of lung and breast cancer cells to trans-platinum as compared to cis-platinum.
[2013]
Janković, Radmila EGFR mutations in advanced non-small cell lung cancer patients in Serbia: 3 year-experience of central testing and gefitinib therapy response.
[2015]
Janković, Radmila Filteri
Po tipu
- 156